Drug maker Krka posts EUR 153m net profit for 2017, up 41% Y/Y
Novo mesto, 22 March - Pharma company Krka saw group net profit increase 41% in 2017 to EUR 152.6m, on sales that rose 8% to EUR 1.27bn, a new record for the company, show unaudited results released on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 646 characters (without spaces) or 131 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.